Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Regeneron Pharmaceuticals Q3 2026 Results: Net Income $1.95B, Up 33.5% YoY

Regeneron reported a significant increase in total revenues to $5.12 billion for the third quarter of 2026, driven by strong collaboration revenue and net product sales. Net income for the quarter rose to $1.95 billion, up from $1.46 billion in the prior year period, despite higher research and development expenses.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue5,115.83,754.3
Profit before tax2,284.11,763.3
Net income1,948.71,460.0
EPS (diluted, $ a share)$18.45$13.62

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+33.5%
Revenue, year on year+36.3%
Operating margin40.0%
Source

10-Q filed with the SEC, NASDAQ: REGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Regeneron Pharmaceuticals, Inc.: key numbers

Share price
$957.76Close, Nov 17
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Regeneron Pharmaceuticals, Inc.

All →
4:02 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals SVP Controller Jason Pitofsky Sells $3.83M of Stock

Jason Pitofsky, SVP Controller, sold 4,062 shares of Regeneron Pharmaceuticals, Inc. at $939.57 to $950.76 a share (average $942.19) in 8 transactions, worth $3.83M in total on Nov 4, 2026. Shares held after the trade: 0 (-100.0%).

Value
$3.83M
Shares
4,062
Average price
$942.19
Role
SVP Controller
Holding change
-100.0%
Trade date
Nov 4, 2026
4:06 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals Insider Huda Y. Zoghbi Sells $7.22M of Stock

Huda Y. Zoghbi sold 7,439 shares of Regeneron Pharmaceuticals, Inc. at $970.42 to $971.06 a share (average $970.46) in 2 transactions, worth $7.22M in total on Nov 3, 2026. Shares held after the trade: 1,703 (-22.7%).

Value
$7.22M
Shares
7,439
Average price
$970.46
Holding change
-22.7%
Trade date
Nov 3, 2026
4:12 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals Insider George L. Sing Sells $20.4M of Stock

George L. Sing sold 21,129 shares of Regeneron Pharmaceuticals, Inc. at $960.57 to $970.18 a share (average $964.38) in 9 transactions, worth $20.4M in total on Nov 2, 2026. Shares held after the trade: 25,147 (-0.8%).

Value
$20.4M
Shares
21,129
Average price
$964.38
Holding change
-0.8%
Trade date
Nov 2, 2026
4:10 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals Insider Christine A. Poon Sells $7.59M of Stock

Christine A. Poon sold 7,830 shares of Regeneron Pharmaceuticals, Inc. at $966.74 to $971.31 a share (average $969.09) in 6 transactions, worth $7.59M in total on Nov 2, 2026. Shares held after the trade: 5,219 (-3.7%).

Value
$7.59M
Shares
7,830
Average price
$969.09
Holding change
-3.7%
Trade date
Nov 2, 2026
4:05 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals EVP General Counsel and Secret Joseph J. Larosa Sells $4.31M of Stock

Joseph J. Larosa, EVP General Counsel and Secret, sold 4,466 shares of Regeneron Pharmaceuticals, Inc. at $965.41 to $966.11 a share (average $965.49) in 2 transactions, worth $4.31M in total on Nov 2, 2026. Shares held after the trade: 38,906 (-1.3%).

Value
$4.31M
Shares
4,466
Average price
$965.49
Role
EVP General Counsel and Secret
Holding change
-1.3%
Trade date
Nov 2, 2026
4:23 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals Insider Kathryn Guarini Sells $360K of Stock

Kathryn Guarini sold 400 shares of Regeneron Pharmaceuticals, Inc. at $900.00 a share, worth $360K in total on Oct 30, 2026. Shares held after the trade: 603 (-39.9%).

Value
$360K
Shares
400
Price
$900.00
Holding change
-39.9%
Trade date
Oct 30, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.